Technology & Promotion

技術

人類誘導式幹細胞技術:次世代細胞治療


    請訪問我們新網頁:https://lumistarbiotech.com/ch
  • Various functional cells can be produced from blood sample by reprogramming and differentiation
  • Functional cells are exploited for organ regeneration

Advantages:

  • Easy for expansion
  • Excellent ability for differentiation
  • Support autologous and allogeneic treatments
  • Flexible for genetic modifications

Human Induced Pluripotent Stem Cells ( hiPSC ) Blood hiPSC PBMCs NK cells for cancer therapy Neuron Cells Cardiomyocytes Renal Cells CRISPR editing or viral transfer methodology Genetic modification of iPSC Reprogramming Differentiation
 

LumiSTAR Cell Therapy Pipelines


Contract Development and Quality Control Platform:  

  • Contract development service for cell differentiation
  • iPSC bioimaging functional testing for quality control of differentiated cells in different batches

Cell Therapy Pipelines:

Chronic Fibrosis (FIPS - i , FIPS - KP, FIPS - Ex ) Parkinsons Disease (NIPS - DN) iPSC Immune Cells (CIPS - NK)